Wealth Enhancement Advisory Services, LLC Vanda Pharmaceuticals Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $65.4 Billion
- Q4 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 23,413 shares of VNDA stock, worth $101,846. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,413
Previous 17,500
33.79%
Holding current value
$101,846
Previous $87,000
16.09%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VNDA
# of Institutions
162Shares Held
45.3MCall Options Held
159KPut Options Held
229K-
Black Rock Inc. New York, NY8.14MShares$35.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$15.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.48MShares$15.1 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.25MShares$14.1 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.56MShares$11.2 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $246M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...